Expands the Right to Try Act to include certain severe illnesses and regenerative stem cell therapies.

New Hampshire HB1292 expands the Right to Try Act to include patients with certain severe illnesses and permits regenerative stem cell therapies. The bill allows eligible patients with terminal or qualifying severe illnesses to access investigational drugs, biologics, or devices not yet approved by the FDA. It also permits physicians to perform stem cell therapies for orthopedics, wound care, or pain management, provided certain conditions are met. The bill aims to foster medical innovation while ensuring ethical standards are upheld.

Expands the Right to Try Act to include certain severe illnesses and regenerative stem cell therapies.

New Hampshire HB1292 expands the Right to Try Act to include patients with certain severe illnesses and permits regenerative stem cell therapies. The bill allows eligible patients with terminal or qualifying severe illnesses to access investigational drugs, biologics, or devices not yet approved by the FDA. It also permits physicians to perform stem cell therapies for orthopedics, wound care, or pain management, provided certain conditions are met. The bill aims to foster medical innovation while ensuring ethical standards are upheld.